- Filter by
- Categories
- Tags
- Authors
- Show all
- All
- Allergy&Clinical Immunology
- Anesthesiology
- Business of Medicine
- Cardiology
- Critical Care
- Dental&Oral Health
- Dermatology
- Diabetes&Endocrinology
- Emergency Medicine
- Family Medicine/Primary Care
- Gastroenterology
- General Surgery
- Hematology-Oncology
- HIV/AIDS
- Hospital Medicine
- Infectious Diseases
- Internal Medicine
- Med Students
- Medscape Today
- Nephrology
- Neurology&Neurosurgery
- News
- News Alert
- None
- Nursing
- Ob/Gyn&Women's Health
- Ophthalmology
- Orthopaedics
- Pathology&Lab Medicine
- Pediatrics
- Pharmacist
- Plastic Surgery&Aesthetic Medicine
- Psychiatry
- Public Health&Prevention
- Pulmonary Medicine
- Radiology
- Rheumatology
- Transplantation
- Urology
December 2, 2022
Published by Med Search on December 2, 2022
Categories
Reference #: 3008307735 Product: Drugs Recipient: Recipient Name Mr. P. R. Bhaskar Reddy Recipient Title Vice President – Operations Hetero Labs Limited Unit V Surv. No. […]
December 1, 2022
Published by Med Search on December 1, 2022
Categories
Recognized Interpretive Criteria Minimum Inhibitory Concentrations(mcg/mL)Broth Microdilutionat 24 Hours Disk Diffusion(zone diameters in mm) Disk Diffusion at 24 Hours Pathogen S I R S I R […]
December 1, 2022
Published by Med Search on December 1, 2022
Categories
This web page provides information about the in vitro susceptibility of fungi to certain drugs. The safety and efficacy of these drugs in treating clinical infections due […]
December 1, 2022
Published by Med Search on December 1, 2022
Categories
Intelence (etravirine) In combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replications and HIV-1 […]
December 1, 2022
Published by Med Search on December 1, 2022
Categories
This listing includes accelerated approvals (AAs) for non-malignant hematological, neurological, and other disorder indications with postmarketing trials that have verified clinical benefit and for which traditional approval has been […]
December 1, 2022
Published by Med Search on December 1, 2022
Categories
This listing includes accelerated approvals (AAs) for infectious disease indications that have postmarketing requirement(s) that have been subsequently withdrawn, and are therefore, no longer FDA-approved. Withdrawn indications are not […]
December 1, 2022
Published by Med Search on December 1, 2022
Categories
This listing includes accelerated approvals (AAs) for infectious disease indications with postmarketing trials that have verified clinical benefit and for which traditional approval has been subsequently granted for the […]
December 1, 2022
Published by Med Search on December 1, 2022
Categories
This listing includes accelerated approvals (AAs) for infectious disease indications that have postmarketing requirement(s) for ongoing clinical trial(s) to verify clinical benefit. Please refer to [email protected] for the latest approvals and […]
December 1, 2022
Published by Med Search on December 1, 2022
Categories
Skysona (elivaldogene autotemcel) Indicated to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (cald) 9/16/2022 PMR 1: […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140
Next page